BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.017
0.00%
(0.00) 1D
Okt 5, 4:10:08 PM GMT+11 · AUD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa BOT...
Mkt. cap
42.25M
Avg. na dami
5.79M
Dami
0.00
Mataas nang 52-wk
A$0.17
Mababa nang 52-wk
A$0.02
EPS
-A$0.03
Mga natitirang share
2.76B
Bilang ng mga empleyado
11
Mkt. cap
42.25M
Avg. na dami
5.79M
Dami
0.00
Mataas nang 52-wk
A$0.17
Mababa nang 52-wk
A$0.02
EPS
-A$0.03
Mga natitirang share
2.76B
Bilang ng mga empleyado
11
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Investing.com
·
2 oras ang nakalipas
Nasdaq notches record high close as investors focus on earnings By Reuters
Reuters
·
9 oras ang nakalipas
COMMENTARY: Wall Street bulls try on ‘S&P 10,000’ caps for size
MarketWatch
·
3 araw ang nakalipas
The stock market is anything but normal right now — and these charts show it
Bloomberg.com
·
6 araw ang nakalipas
Stocks and Bonds Pause Ahead of US Data, Micron: Markets Wrap
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Tungkol sa Botanix Pharmaceuticals Ltd